Trogenix
Trogenix is a startup headquartered in London, United Kingdom, founded in 2023. It has won about £767k in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Trogenix has won about £767k in competitive Innovate UK grants since 2023.
- Development of a novel AAV cancer gene therapy for liver hepatocellular carcinoma and colorectal cancer (£767k, 2024)
R&D ecosystem
Trogenix sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in London
- Abtrace
- Adjsoft
- Aeon Energy
- Amphibio
- Anserine Labs
- APIContext
- Apoha
- AppyParking
- Archangel Lightworks
- Arda Biomaterials
- Bark
Related
- Innovation profile of London
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Trogenix do?
Trogenix works in biotechnology. Its Innovate UK projects include: Development of a novel AAV cancer gene therapy for liver hepatocellular carcinoma and colorectal cancer.
Where is Trogenix based?
Trogenix is headquartered in London, United Kingdom.
When was Trogenix founded?
Trogenix was founded in 2023.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.